![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 1, 9-12, January 4, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
and Regulates Its
Stability*
,
,
,
,
,
,
From the Hypoxia-inducible factor-1 (HIF-1) is a master
transcription factor that controls transcriptional activation of a
number of genes responsive to the low cellular oxygen tension,
including vascular endothelial growth factor (VEGF), erythropoietin,
and glycolytic enzymes. The stability and activity of HIF-1
Department of Molecular Biology, Pusan
National University, Pusan 609-735, Korea, the § Department
of Pharmacology, College of Medicine, Seoul National University, Seoul
110-799, Korea, and the ¶ Research Institute of Pharmaceutical
Sciences, College of Pharmacy, Seoul National University, Seoul
151-742, Korea
are
regulated by binding to various proteins such as pVHL, p53, and
p300/CBP. Here, using the yeast two-hybrid screening system, we found
that HIF-1
interacts with Jab1 (Jun activation domain-binding
protein-1), which is a coactivator of AP-1 transcription factor and
fifth subunit of COP9 signalosome complex. The interaction of
Jab1 with HIF-1
was confirmed by GST pull-down assay and also
reproduced in vivo in HEK 293 cells, where endogenous Jab1
was coimmunoprecipitated with the overexpressed HIF-1
. Moreover,
Jab1-enhanced transcriptional activity of HIF-1 under hypoxia led to
increase the expression of VEGF, a major HIF-1 target gene.
Furthermore, Jab1 increased HIF-1
protein levels, which was due to
the enhanced HIF-1
stability. The binding of HIF-1
and p53 tumor
suppressor protein, negative regulator of HIF-1
stability, was
interfered in a Jab1-dependent manner. Taken together,
these results indicate that Jab1 should be considered as a novel
regulator of HIF-1
stability via direct interaction.
To whom correspondence should be addressed: College of
Pharmacy, Seoul National University, Seoul 151-742, Korea. Tel.:
82-2-880-6988; Fax: 82-2-872-1795; E-mail:
qwonkim@plaza.snu.ac.kr.
This article has been cited by other articles:
![]() |
M.-C. Hsu, C.-C. Huang, H.-C. Chang, T.-H. Hu, and W.-C. Hung Overexpression of Jab1 in Hepatocellular Carcinoma and Its Inhibition by Peroxisome Proliferator-Activated Receptor{gamma} Ligands In vitro and In vivo Clin. Cancer Res., July 1, 2008; 14(13): 4045 - 4052. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Miyauchi, M. Kato, F. Tokunaga, and K. Iwai The COP9/Signalosome Increases the Efficiency of von Hippel-Lindau Protein Ubiquitin Ligase-mediated Hypoxia-inducible Factor-{alpha} Ubiquitination J. Biol. Chem., June 13, 2008; 283(24): 16622 - 16631. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Adler, L. E. Littlepage, M. Lin, T. L.A. Kawahara, D. J. Wong, Z. Werb, and H. Y. Chang CSN5 Isopeptidase Activity Links COP9 Signalosome Activation to Breast Cancer Progression Cancer Res., January 15, 2008; 68(2): 506 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Hsieh, I.-J. Su, H.-C. Wang, J.-H. Tsai, Y.-J. Huang, W.-W. Chang, M.-D. Lai, H.-Y. Lei, and W. Huang Hepatitis B Virus Pre-S2 Mutant Surface Antigen Induces Degradation of Cyclin-Dependent Kinase Inhibitor p27Kip1 through c-Jun Activation Domain-Binding Protein 1 Mol. Cancer Res., October 1, 2007; 5(10): 1063 - 1072. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Lim, J.-W. Park, S. J. Kim, M.-S. Kim, S.-K. Park, R. S. Johnson, and Y.-S. Chun ATP6V0C Competes with Von Hippel-Lindau Protein in Hypoxia-Inducible Factor 1{alpha} (HIF-1{alpha}) Binding and Mediates HIF-1{alpha} Expression by Bafilomycin A1 Mol. Pharmacol., March 1, 2007; 71(3): 942 - 948. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Ke and M. Costa Hypoxia-Inducible Factor-1 (HIF-1) Mol. Pharmacol., November 1, 2006; 70(5): 1469 - 1480. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, C. Li, Y. Liu, W. Mei, S. Yu, C. Liu, L. Zhang, X. Cao, R. P. Kimberly, W. Grizzle, et al. JAB1 Determines the Response of Rheumatoid Arthritis Synovial Fibroblasts to Tumor Necrosis Factor-{alpha} Am. J. Pathol., September 1, 2006; 169(3): 889 - 902. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Kang, H. J. Kim, J.-K. Rih, T. L. Mattson, K. W. Kim, C.-H. Cho, J. S. Isaacs, and I. Bae BRCA1 Plays a Role in the Hypoxic Response by Regulating HIF-1{alpha} Stability and by Modulating Vascular Endothelial Growth Factor Expression J. Biol. Chem., May 12, 2006; 281(19): 13047 - 13056. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Luo, Y. Wang, T. Hanck, R. Stricker, and G. Reiser Jab1, a Novel Protease-activated Receptor-2 (PAR-2)-interacting Protein, Is Involved in PAR-2-induced Activation of Activator Protein-1 J. Biol. Chem., March 24, 2006; 281(12): 7927 - 7936. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Richardson and W. Zundel The Emerging Role of the COP9 Signalosome in Cancer Mol. Cancer Res., December 1, 2005; 3(12): 645 - 653. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Wenger, D. P. Stiehl, and G. Camenisch Integration of Oxygen Signaling at the Consensus HRE Sci. Signal., October 18, 2005; 2005(306): re12 - re12. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Y. Hong, J. H. Suh, K. Kim, E.-Y. Gong, S. H. Jeon, M. Ko, R. H. Seong, H. B. Kwon, and K. Lee Modulation of Androgen Receptor Transactivation by the SWI3-Related Gene Product (SRG3) in Multiple Ways Mol. Cell. Biol., June 15, 2005; 25(12): 4841 - 4852. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tomoda, J.-y. Kato, E. Tatsumi, T. Takahashi, Y. Matsuo, and N. Yoneda-Kato The Jab1/COP9 signalosome subcomplex is a downstream mediator of Bcr-Abl kinase activity and facilitates cell-cycle progression Blood, January 15, 2005; 105(2): 775 - 783. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tomoda, N. Yoneda-Kato, A. Fukumoto, S. Yamanaka, and J.-y. Kato Multiple Functions of Jab1 Are Required for Early Embryonic Development and Growth Potential in Mice J. Biol. Chem., October 8, 2004; 279(41): 43013 - 43018. [Abstract] [Full Text] [PDF] |
||||
![]() |
A E Greijer and E van der Wall The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis J. Clin. Pathol., October 1, 2004; 57(10): 1009 - 1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bemis, D. A. Chan, C. V. Finkielstein, L. Qi, P. D. Sutphin, X. Chen, K. Stenmark, A. J. Giaccia, and W. Zundel Distinct aerobic and hypoxic mechanisms of HIF-{alpha} regulation by CSN5 Genes & Dev., April 1, 2004; 18(7): 739 - 744. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-C. Kim, H.-J. Lee, S. H. Park, S. R. Lee, T. S. Karpova, J. G. McNally, A. Felici, D. K. Lee, and S.-J. Kim Jab1/CSN5, a Component of the COP9 Signalosome, Regulates Transforming Growth Factor {beta} Signaling by Binding to Smad7 and Promoting Its Degradation Mol. Cell. Biol., March 15, 2004; 24(6): 2251 - 2262. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Seta and D. E. Millhorn Functional genomics approach to hypoxia signaling J Appl Physiol, February 1, 2004; 96(2): 765 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Esteva, A. A. Sahin, G. Z. Rassidakis, L. X. H. Yuan, T. L. Smith, Y. Yang, M. Z. Gilcrease, M. Cristofanilli, R. Nahta, L. Pusztai, et al. Jun Activation Domain Binding Protein 1 Expression Is Associated with Low p27Kip1Levels in Node-Negative Breast Cancer Clin. Cancer Res., November 15, 2003; 9(15): 5652 - 5659. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Masson and P. J. Ratcliffe HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O2 levels J. Cell Sci., August 1, 2003; 116(15): 3041 - 3049. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Kouvaraki, G. Z. Rassidakis, L. Tian, R. Kumar, C. Kittas, and F.-X. Claret Jun Activation Domain-binding Protein 1 Expression in Breast Cancer Inversely Correlates with the Cell Cycle Inhibitor p27Kip1 Cancer Res., June 1, 2003; 63(11): 2977 - 2981. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Emberley, Y. Niu, E. Leygue, L. Tomes, R. D. Gietz, L. C. Murphy, and P. H. Watson Psoriasin Interacts with Jab1 and Influences Breast Cancer Progression Cancer Res., April 15, 2003; 63(8): 1954 - 1961. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. WENGER Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression FASEB J, August 1, 2002; 16(10): 1151 - 1162. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |